CTTH
CTT PHARMACEUTICAL HOLDINGS, INC.
Key Financials
Net Income
$227838
↑ 106.3%
Operating Income
$-672162
↓ 829.0%
Shareholders' Equity
$586630.00
↑ 341.3%
EPS (Diluted)
$0.01
↑ 109.1%
Total Liabilities
$1.1M
↑ 331.4%
Total Assets
$1.7M
↑ 26489.4%
Cash & Equivalents
$81179.00
↑ 9763.8%
Operating Cash Flow
$-72250.00
↑ 47.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-1/A | 4/15/2026 | View on SEC |
| S-1 | 12/30/2025 | View on SEC |
| 4 | 12/17/2025 | View on SEC |
| 4 | 11/24/2025 | View on SEC |
| 4 | 11/21/2025 | View on SEC |
| 4 | 10/31/2025 | View on SEC |
| 4 | 10/7/2025 | View on SEC |
| 4 | 9/23/2025 | View on SEC |
| 4 | 8/1/2025 | View on SEC |
| 4 | 7/8/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CTTH |
| Company Name | CTT PHARMACEUTICAL HOLDINGS, INC. |
| CIK | 1035422 |
| Sector | Pharmaceutical Preparations |
| Industry | Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 813-606-0060 |